Luca Valenti
Universita degli Studi di Milano
Professor, Life Sciences
Italy
My co-authors include
Dr. Oscar Borsani
Professor daniela cabibi
Dr Massimiliano Ruscica
My Publications
Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty L...
Current Pharmaceutical Design
April 2020
Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update
Current Pharmaceutical Design
February 2019
Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver dis...
Liver International
October 2018
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat...
Hepatology Communications
April 2018
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoh...
Journal of Internal Medicine
December 2017
Mutant PNPLA3 I148M protein as pharmacological target for liver disease
Hepatology
August 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patients
Liver International
July 2017
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in pat...
Cancer Medicine
July 2017
Editorial: new insights into the relationship between the intestine and non-alcoholic f...
Alimentary Pharmacology & Therapeutics (Suppl)
July 2017
Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and L...
The Journal of Clinical Endocrinology & Metabolism
May 2017
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Liver International
June 2016
Hepcidin resistance in dysmetabolic iron overload
Liver International
April 2016
The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 ex...
Hepatology
January 2016
Reply
Hepatology
July 2015
Reply
Hepatology
June 2015
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver ...
Hepatology
May 2015
Particulate matter phagocytosis induces tissue factor in differentiating macrophages
Journal of Applied Toxicology
April 2015
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepat...
Hepatology
January 2015
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatoh...
Liver International
November 2014
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independe...
European Journal of Clinical Investigation
June 2014
CDKN1A: A double-edged sword in fatty liver?
Cell Cycle
April 2014
Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patient...
Hepatology
August 2013
PNPLA3 Ile148Met variant and hepatocellular carcinoma: A matter of fat
Digestive and Liver Disease
December 2012
I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology
Hepatology
June 2012
Iron and the Adipocyte: Beware the Liver!
ImmunoGastroenterology
January 2012
Diagnostic and therapeutic implications of the association between ferritin level and s...
World Journal of Gastroenterology
January 2012
Patatin-like phospholipase domain containing-3gene I148M polymorphism, steatosis, and l...
World Journal of Gastroenterology
January 2012
Modulation of Iron Metabolism and Hepcidin Release by HFE Mutations in Chronic Hemodial...
November 2011
PNPLA3 I148M polymorphism and liver damage in obese children
The Journal of Pediatrics
November 2011
Patatin-like phospholipase domain-containing protein 3 genotype and hepatocellular carc...
Hepatology
April 2011
Reply
Hepatology
March 2010
Reply:
Hepatology
December 2008
Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resis...
Hepatology
November 2008
HFEmutations in nonalcoholic fatty liver disease
Hepatology
April 2008
Turning up the heat in the fat cell
news nature com
November 2004
Effect of iron depletion in patients with nonalcoholic fatty liver disease without carb...
Gastroenterology
March 2003
TNFα Promoter Polymorphisms